Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X9LC
|
|||
| Former ID |
DIB009474
|
|||
| Drug Name |
IC-41
|
|||
| Synonyms |
TRANSVAX HCV, Intercell; Vaccine (HCV), Intercell; Vaccine (hepatitis C virus), Intercell; HCV-derived peptides + IC-30 (synthetic Th1/Tc1 poly-L-arginine) adjuvant (HCV), Intercell
Click to Show/Hide
|
|||
| Indication | Hepatitis virus infection [ICD-11: 1E50-1E51; ICD-9: 573.3] | Phase 2 | [1] | |
| Company |
Intercell
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00601770) Virological Response Study of the HCV Vaccine IC41. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.